ECOR · XBRL financial data

electroCore financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ECOR's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	3,496	5,451	8,592	16,030	25,182	32,032
Cost of goods and services sold	1,738	1,385	1,616	2,804	3,785	4,244
Gross profit	1,758	4,066	6,976	13,226	21,397	27,788
Research and development	4,201	2,536	5,520	5,321	2,360	—
Selling, general and administrative	21,841	21,573	24,330	27,174	31,199	38,206
Total operating expenses	26,507	24,109	29,850	32,495	33,559	40,941
Operating income (loss)	(24,749)	(20,043)	(22,874)	(19,269)	(12,162)	(13,153)
Interest expense	0	—	4	—	18	15
Other income (expense)	—	—	—	—	183	(810)
Income tax expense (benefit)	(1,171)	(851)	(431)	(186)	(93)	3
Net income (loss)	(23,511)	(17,218)	(22,162)	(18,834)	(11,886)	(13,966)
Earnings per share, basic USD per share	—	(4.36)	(4.69)	(3.42)	(1.59)	(1.65)
Earnings per share, diluted USD per share	—	(4.36)	(4.69)	(3.42)	(1.59)	(1.65)
Weighted average shares, basic thousands of shares	—	4	5	6	7,483	8
Weighted average shares, diluted thousands of shares	—	4	5	6	7,483	8

† Share count changed about 1/15 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (ECOR's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	4,242	34,689	17,712	10,331	3,450	7,035
Marketable securities	18,386	—	—	—	8,519	4,576
Accounts receivable	271	438	401	717	1,367	1,027
Inventory	876	1,361	1,982	2,160	1,676	1,631
Prepaid and other current assets	1,289	1,054	828	836	1,038	1,397
Total current assets	25,064	37,541	21,173	14,294	16,300	15,666
Property and equipment, net	244	147	50	204	158	382
Right-of-use asset	517	613	565	502	3,739	2,565
Total assets	31,518	42,833	24,756	16,102	20,471	18,667
Accounts payable	2,079	1,543	2,129	2,163	1,827	2,712
Accrued liabilities	2,801	3,881	4,842	5,871	6,964	8,261
Total current liabilities	5,890	5,485	7,045	8,123	9,152	11,348
Long-term debt	—	—	—	—	—	6,607
Lease liability, non-current	885	699	625	537	3,775	2,421
Total liabilities	7,874	6,185	7,670	8,660	12,927	20,376
Accumulated deficit	(106,990)	(124,208)	(146,370)	(165,204)	(177,090)	(191,056)
Total stockholders' equity	23,009	36,648	17,086	7,442	7,544	(1,709)
Total liabilities and equity	31,518	42,833	24,756	16,102	20,471	18,667
Common shares outstanding (cover page) thousands of shares	48,477	70,718	4,742	6,003	7,193	8,084

† Share count changed about 1/15 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (ECOR's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(23,511)	(17,218)	(22,162)	(18,834)	(11,886)	(13,966)
Stock-based compensation	3,266	3,302	2,682	1,698	1,870	1,930
Depreciation and amortization	399	382	548	962	760	—
Net cash from operating activities	(20,103)	(13,628)	(16,645)	(14,668)	(6,948)	(8,187)
Purchases of property and equipment	—	—	—	206	—	66
Net cash from investing activities	(7,963)	18,217	—	(206)	(8,519)	3,877
Proceeds from issuing common stock	—	—	—	8,144	—	—
Proceeds from long-term debt	—	—	—	—	—	7,500
Net cash from financing activities	18,952	25,682	—	7,487	8,439	7,627
Net change in cash	(9,322)	30,447	(16,727)	(7,381)	(6,881)	—

† Share count changed about 1/15 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
electroCore	8,501	9,450	(3,518)*	9.0M	2.9 quarters	Q2 FY26 10-QJun 30, 2026
DarioHealth	6,634	not reported	(6,083)*	9.8M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
Nephros	4,697	6,017	681*	10.9M	—	Q2 FY26 10-QJun 30, 2026
RenovoRx	9,479	909	(2,867)*	45.1M	3.3 quarters	Q2 FY26 10-QJun 30, 2026
Femasys	1,444	332	(3,936)*	8.4M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Precision Optics	9,841	8,774*	(649)*	11.0M	15.2 quarters	Q4 FY26 10-KJun 30, 2026
Neuroone Medical Technologies	2,048	1,973	(1,082)*	9.1M	1.9 quarters	Q3 FY26 10-QJun 30, 2026
United Health Products	24	0	(138)*	262.7M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Cerenome	2,366	411	(7,132)*	7.6M	1.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.